Low blood pressure in endothelial cell-specific endothelin 1 knockout mice

Yaz Y. Kisanuki, Noriaki Emoto, Takashi Ohuchi, Bambang Widyantoro, Keiko Yagi, Kazuhiko Nakayama, Rafal Kedzierski, Robert E. Hammer, Hiromi Yanagisawa, S. Clay Williams, James A. Richardson, Takashi Suzuki, Masashi Yanagisawa

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Endothelin (ET) 1 is a potent vasoconstrictor peptide produced by vascular endothelial cells and implicated in various pathophysiologic states involving abnormal vascular tone. Homozygous ET-1 null mice have craniofacial and cardiac malformations that lead to neonatal death. To study the role of ET-1 in adult vascular physiology, we generated a mouse strain (ET-1flox/flox;Tie2- Cre mice) in which ET-1 is disrupted specifically in endothelial cells. ET-1 peptide levels in plasma, heart, lung, kidney, and brain homogenates were reduced by 65% to 80% in these mice. mRNA levels for ET Areceptors were unaltered except that the ETA receptor mRNA was upregulated in the heart. ET-1flox/flox;Tie2-Cre mice had mean blood pressures 10 to 12 mm Hg lower than genetic controls. In contrast, the blood pressure of mice systemically heterozygous for the ET-1 null allele (ET-1 mice) was unchanged compared with wild-type littermates. Despite the lower basal blood pressure, acute pharmacological responses to angiotensin II, captopril, phenylephrine, bradykinin, N-nitro-l-arginine methyl ester, and exogenous ET-1 were normal in ET-1;Tie2-Cre mice. These results support an essential role of endothelial-derived ET-1 in the maintenance of basal vascular tone and blood pressure. Normal pharmacological responses of ET-1;Tie2-Cre mice suggest that the renin-angiotensin system, the adrenergic system, and NO are not significantly altered by endothelial ET-1. Taken in conjunction with other lines of genetically altered mice, our results provide evidence for a paracrine vasoregulatory pathway mediated by endothelial cell-derived ET-1 acting on the vascular smooth muscle ETA receptor.

Original languageEnglish (US)
Pages (from-to)121-128
Number of pages8
JournalHypertension
Volume56
Issue number1
DOIs
StatePublished - Jul 1 2010
Externally publishedYes

Fingerprint

Endothelin-1
Knockout Mice
Hypotension
Endothelial Cells
Endothelins
Blood Pressure
Blood Vessels
Pharmacology
Messenger RNA
Peptides
Captopril
Bradykinin
Phenylephrine
Vasoconstrictor Agents
Renin-Angiotensin System
Vascular Smooth Muscle
Angiotensin II
Adrenergic Agents
Alleles
Maintenance

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Kisanuki, Y. Y., Emoto, N., Ohuchi, T., Widyantoro, B., Yagi, K., Nakayama, K., ... Yanagisawa, M. (2010). Low blood pressure in endothelial cell-specific endothelin 1 knockout mice. Hypertension, 56(1), 121-128. https://doi.org/10.1161/HYPERTENSIONAHA.109.138701

Low blood pressure in endothelial cell-specific endothelin 1 knockout mice. / Kisanuki, Yaz Y.; Emoto, Noriaki; Ohuchi, Takashi; Widyantoro, Bambang; Yagi, Keiko; Nakayama, Kazuhiko; Kedzierski, Rafal; Hammer, Robert E.; Yanagisawa, Hiromi; Williams, S. Clay; Richardson, James A.; Suzuki, Takashi; Yanagisawa, Masashi.

In: Hypertension, Vol. 56, No. 1, 01.07.2010, p. 121-128.

Research output: Contribution to journalArticle

Kisanuki, YY, Emoto, N, Ohuchi, T, Widyantoro, B, Yagi, K, Nakayama, K, Kedzierski, R, Hammer, RE, Yanagisawa, H, Williams, SC, Richardson, JA, Suzuki, T & Yanagisawa, M 2010, 'Low blood pressure in endothelial cell-specific endothelin 1 knockout mice', Hypertension, vol. 56, no. 1, pp. 121-128. https://doi.org/10.1161/HYPERTENSIONAHA.109.138701
Kisanuki YY, Emoto N, Ohuchi T, Widyantoro B, Yagi K, Nakayama K et al. Low blood pressure in endothelial cell-specific endothelin 1 knockout mice. Hypertension. 2010 Jul 1;56(1):121-128. https://doi.org/10.1161/HYPERTENSIONAHA.109.138701
Kisanuki, Yaz Y. ; Emoto, Noriaki ; Ohuchi, Takashi ; Widyantoro, Bambang ; Yagi, Keiko ; Nakayama, Kazuhiko ; Kedzierski, Rafal ; Hammer, Robert E. ; Yanagisawa, Hiromi ; Williams, S. Clay ; Richardson, James A. ; Suzuki, Takashi ; Yanagisawa, Masashi. / Low blood pressure in endothelial cell-specific endothelin 1 knockout mice. In: Hypertension. 2010 ; Vol. 56, No. 1. pp. 121-128.
@article{c0a59eade800469d963db2fa1d83f4d3,
title = "Low blood pressure in endothelial cell-specific endothelin 1 knockout mice",
abstract = "Endothelin (ET) 1 is a potent vasoconstrictor peptide produced by vascular endothelial cells and implicated in various pathophysiologic states involving abnormal vascular tone. Homozygous ET-1 null mice have craniofacial and cardiac malformations that lead to neonatal death. To study the role of ET-1 in adult vascular physiology, we generated a mouse strain (ET-1flox/flox;Tie2- Cre mice) in which ET-1 is disrupted specifically in endothelial cells. ET-1 peptide levels in plasma, heart, lung, kidney, and brain homogenates were reduced by 65{\%} to 80{\%} in these mice. mRNA levels for ET Areceptors were unaltered except that the ETA receptor mRNA was upregulated in the heart. ET-1flox/flox;Tie2-Cre mice had mean blood pressures 10 to 12 mm Hg lower than genetic controls. In contrast, the blood pressure of mice systemically heterozygous for the ET-1 null allele (ET-1 mice) was unchanged compared with wild-type littermates. Despite the lower basal blood pressure, acute pharmacological responses to angiotensin II, captopril, phenylephrine, bradykinin, N-nitro-l-arginine methyl ester, and exogenous ET-1 were normal in ET-1;Tie2-Cre mice. These results support an essential role of endothelial-derived ET-1 in the maintenance of basal vascular tone and blood pressure. Normal pharmacological responses of ET-1;Tie2-Cre mice suggest that the renin-angiotensin system, the adrenergic system, and NO are not significantly altered by endothelial ET-1. Taken in conjunction with other lines of genetically altered mice, our results provide evidence for a paracrine vasoregulatory pathway mediated by endothelial cell-derived ET-1 acting on the vascular smooth muscle ETA receptor.",
author = "Kisanuki, {Yaz Y.} and Noriaki Emoto and Takashi Ohuchi and Bambang Widyantoro and Keiko Yagi and Kazuhiko Nakayama and Rafal Kedzierski and Hammer, {Robert E.} and Hiromi Yanagisawa and Williams, {S. Clay} and Richardson, {James A.} and Takashi Suzuki and Masashi Yanagisawa",
year = "2010",
month = "7",
day = "1",
doi = "10.1161/HYPERTENSIONAHA.109.138701",
language = "English (US)",
volume = "56",
pages = "121--128",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Low blood pressure in endothelial cell-specific endothelin 1 knockout mice

AU - Kisanuki, Yaz Y.

AU - Emoto, Noriaki

AU - Ohuchi, Takashi

AU - Widyantoro, Bambang

AU - Yagi, Keiko

AU - Nakayama, Kazuhiko

AU - Kedzierski, Rafal

AU - Hammer, Robert E.

AU - Yanagisawa, Hiromi

AU - Williams, S. Clay

AU - Richardson, James A.

AU - Suzuki, Takashi

AU - Yanagisawa, Masashi

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Endothelin (ET) 1 is a potent vasoconstrictor peptide produced by vascular endothelial cells and implicated in various pathophysiologic states involving abnormal vascular tone. Homozygous ET-1 null mice have craniofacial and cardiac malformations that lead to neonatal death. To study the role of ET-1 in adult vascular physiology, we generated a mouse strain (ET-1flox/flox;Tie2- Cre mice) in which ET-1 is disrupted specifically in endothelial cells. ET-1 peptide levels in plasma, heart, lung, kidney, and brain homogenates were reduced by 65% to 80% in these mice. mRNA levels for ET Areceptors were unaltered except that the ETA receptor mRNA was upregulated in the heart. ET-1flox/flox;Tie2-Cre mice had mean blood pressures 10 to 12 mm Hg lower than genetic controls. In contrast, the blood pressure of mice systemically heterozygous for the ET-1 null allele (ET-1 mice) was unchanged compared with wild-type littermates. Despite the lower basal blood pressure, acute pharmacological responses to angiotensin II, captopril, phenylephrine, bradykinin, N-nitro-l-arginine methyl ester, and exogenous ET-1 were normal in ET-1;Tie2-Cre mice. These results support an essential role of endothelial-derived ET-1 in the maintenance of basal vascular tone and blood pressure. Normal pharmacological responses of ET-1;Tie2-Cre mice suggest that the renin-angiotensin system, the adrenergic system, and NO are not significantly altered by endothelial ET-1. Taken in conjunction with other lines of genetically altered mice, our results provide evidence for a paracrine vasoregulatory pathway mediated by endothelial cell-derived ET-1 acting on the vascular smooth muscle ETA receptor.

AB - Endothelin (ET) 1 is a potent vasoconstrictor peptide produced by vascular endothelial cells and implicated in various pathophysiologic states involving abnormal vascular tone. Homozygous ET-1 null mice have craniofacial and cardiac malformations that lead to neonatal death. To study the role of ET-1 in adult vascular physiology, we generated a mouse strain (ET-1flox/flox;Tie2- Cre mice) in which ET-1 is disrupted specifically in endothelial cells. ET-1 peptide levels in plasma, heart, lung, kidney, and brain homogenates were reduced by 65% to 80% in these mice. mRNA levels for ET Areceptors were unaltered except that the ETA receptor mRNA was upregulated in the heart. ET-1flox/flox;Tie2-Cre mice had mean blood pressures 10 to 12 mm Hg lower than genetic controls. In contrast, the blood pressure of mice systemically heterozygous for the ET-1 null allele (ET-1 mice) was unchanged compared with wild-type littermates. Despite the lower basal blood pressure, acute pharmacological responses to angiotensin II, captopril, phenylephrine, bradykinin, N-nitro-l-arginine methyl ester, and exogenous ET-1 were normal in ET-1;Tie2-Cre mice. These results support an essential role of endothelial-derived ET-1 in the maintenance of basal vascular tone and blood pressure. Normal pharmacological responses of ET-1;Tie2-Cre mice suggest that the renin-angiotensin system, the adrenergic system, and NO are not significantly altered by endothelial ET-1. Taken in conjunction with other lines of genetically altered mice, our results provide evidence for a paracrine vasoregulatory pathway mediated by endothelial cell-derived ET-1 acting on the vascular smooth muscle ETA receptor.

UR - http://www.scopus.com/inward/record.url?scp=77953762427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953762427&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.109.138701

DO - 10.1161/HYPERTENSIONAHA.109.138701

M3 - Article

VL - 56

SP - 121

EP - 128

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 1

ER -